| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
  free 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
  free 
  free 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Human metapneumovirus in paediatric patients Principi N; Bosis S; Esposito SClin Microbiol Infect  2006[Apr]; 12 (4): 301-8Acute respiratory tract infections (ARTIs) are a leading cause of morbidity and  mortality in children worldwide, but the aetiology of many ARTIs is still  unknown. In 2001, researchers in The Netherlands reported the discovery of a  previously unidentified pathogen called human metapneumovirus (hMPV). Since its  initial description, hMPV has been associated with ARTI in Europe (Italy, France,  Spain, the UK, Germany, Denmark, Finland and Norway), America (the USA, Canada,  Argentina and Brazil), Asia (India, Japan, China and Singapore), Australia and  South Africa in individuals of all ages. The incidence of infection varies from  1.5% to 25%, indicating that hMPV is a ubiquitous virus with a worldwide  distribution. hMPV seems to play an important role as a cause of paediatric upper  and lower respiratory tract infection, with similar, but not identical,  epidemiological and clinical features to those of respiratory syncytial virus and  influenza virus. Moreover, the socio-economic impact of hMPV-infected children on  their families seems to be considerable, which suggests that, like influenza  virus, hMPV infection may be a substantial public health problem for the  community. It may be associated with significant morbidity and mortality in  pre-term infants and children with underlying clinical conditions, although more  adequately controlled studies are needed to confirm its importance in such  patients. Many fundamental questions concerning the pathogenesis of hMPV disease  and the host's specific immune response remain to be answered. Further studies  are also required to properly define hMPV diagnosis, treatment and prevention  strategies.|Animals[MESH]|Child[MESH]|Humans[MESH]|Metapneumovirus/*isolation & purification/*pathogenicity[MESH]|Paramyxoviridae Infections/*diagnosis/therapy/*virology[MESH]|Respiratory Tract Infections/*diagnosis/therapy/*virology[MESH]
 |